See more : Flag Ship Acquisition Corp. Ordinary Shares (FSHP) Income Statement Analysis – Financial Results
Complete financial analysis of Shree Ganesh Remedies Limited (SGRL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shree Ganesh Remedies Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Ryder System, Inc. (R) Income Statement Analysis – Financial Results
- FuSheng Precision Co., Ltd. (6670.TW) Income Statement Analysis – Financial Results
- TS Lines Ltd (2510.HK) Income Statement Analysis – Financial Results
- Baida Group Co.,Ltd (600865.SS) Income Statement Analysis – Financial Results
- Alinma Hospitality REIT Fund (4349.SR) Income Statement Analysis – Financial Results
Shree Ganesh Remedies Limited (SGRL.BO)
About Shree Ganesh Remedies Limited
Shree Ganesh Remedies Ltd. engages in the research, development, manufacture, and marketing of healthcare products. Its products include intermediate and pharmaceuticals, veterinary products, and bulk drugs. The company was founded on April 27, 1995 and is headquartered in Ankleshwar, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.26B | 902.20M | 712.88M | 490.82M | 584.26M | 353.14M | 272.61M | 198.59M | 155.21M | 164.97M | 183.48M | 127.81M |
| Cost of Revenue | 584.78M | 471.64M | 370.52M | 220.18M | 356.99M | 184.92M | 149.13M | 102.11M | 85.45M | 93.32M | 90.86M | 65.28M |
| Gross Profit | 674.18M | 430.56M | 342.36M | 270.64M | 227.26M | 168.22M | 123.48M | 96.47M | 69.76M | 71.65M | 92.63M | 62.53M |
| Gross Profit Ratio | 53.55% | 47.72% | 48.02% | 55.14% | 38.90% | 47.64% | 45.30% | 48.58% | 44.95% | 43.43% | 50.48% | 48.92% |
| Research & Development | 235.00K | 20.80M | 19.80M | 7.56M | 0.00 | 0.00 | 0.00 | 2.02K | 1.00K | 1.00K | 39.00K | 0.00 |
| General & Administrative | 9.36M | 6.60M | 5.45M | 4.74M | 3.04M | 2.76M | 2.89M | 3.50M | 978.00K | 1.60M | 1.04M | 915.00K |
| Selling & Marketing | 13.59M | 12.09M | 3.55M | 3.31M | 2.78M | 2.16M | 1.03M | 926.70K | 683.00K | 797.00K | 880.00K | 847.00K |
| SG&A | 97.65M | 18.69M | 9.00M | 8.05M | 5.82M | 4.92M | 3.92M | 4.42M | 1.66M | 2.39M | 1.92M | 1.76M |
| Other Expenses | 0.00 | 407.00K | 543.00K | 5.81M | 15.53M | 155.74K | 2.72M | 1.64M | 1.30M | 632.00K | 1.21M | 1.53M |
| Operating Expenses | 104.14M | 227.43M | 191.41M | 158.07M | 136.11M | 87.16M | 77.56M | 61.11M | 56.47M | 56.19M | 51.71M | 43.68M |
| Cost & Expenses | 686.47M | 699.07M | 561.93M | 378.25M | 493.10M | 272.08M | 226.69M | 163.22M | 141.91M | 149.51M | 142.56M | 108.96M |
| Interest Income | 646.00K | 1.35M | 1.52M | 1.60M | 1.74M | 1.13M | 1.89M | 1.26M | 513.00K | 154.00K | 67.00K | 508.00K |
| Interest Expense | 6.07M | 446.00K | 1.05M | 304.00K | 869.66K | 1.67M | 768.78K | 164.13K | 138.00K | 807.00K | 987.00K | 2.36M |
| Depreciation & Amortization | 61.10M | 37.86M | 33.99M | 27.87M | 22.97M | 10.68M | 5.96M | 5.45M | 6.04M | 6.48M | 5.40M | 5.42M |
| EBITDA | 448.77M | 264.87M | 184.71M | 158.03M | 151.78M | 98.98M | 71.53M | 42.43M | 20.51M | 22.42M | 47.38M | 29.86M |
| EBITDA Ratio | 35.65% | 29.41% | 29.87% | 32.01% | 26.08% | 28.31% | 25.91% | 22.65% | 14.48% | 16.05% | 29.41% | 23.34% |
| Operating Income | 572.49M | 205.91M | 153.25M | 114.47M | 92.06M | 81.44M | 46.11M | 39.53M | 16.44M | 20.00M | 48.56M | 24.41M |
| Operating Income Ratio | 45.47% | 22.82% | 21.50% | 23.32% | 15.76% | 23.06% | 16.91% | 19.91% | 10.59% | 12.12% | 26.47% | 19.10% |
| Total Other Income/Expenses | -190.89M | -109.92M | 129.09M | -66.13M | -68.34M | -43.69M | -21.15M | -31.50M | 3.01M | 3.60M | 6.65M | -2.33M |
| Income Before Tax | 381.60M | 225.84M | 180.05M | 129.50M | 127.44M | 86.66M | 64.76M | 39.46M | 16.31M | 19.05M | 47.57M | 22.08M |
| Income Before Tax Ratio | 30.31% | 25.03% | 25.26% | 26.38% | 21.81% | 24.54% | 23.75% | 19.87% | 10.51% | 11.55% | 25.93% | 17.27% |
| Income Tax Expense | 100.52M | 55.64M | 46.07M | 31.95M | 31.19M | 24.31M | 17.88M | 13.08M | 5.47M | 6.31M | 15.42M | 7.24M |
| Net Income | 281.08M | 170.20M | 133.99M | 97.54M | 96.25M | 62.35M | 46.87M | 26.38M | 10.84M | 12.75M | 32.15M | 14.84M |
| Net Income Ratio | 22.33% | 18.87% | 18.80% | 19.87% | 16.47% | 17.66% | 17.19% | 13.29% | 6.98% | 7.73% | 17.52% | 11.61% |
| EPS | 22.34 | 13.86 | 11.08 | 8.07 | 7.14 | 5.16 | 4.56 | 2.18 | 0.90 | 1.05 | 2.66 | 1.23 |
| EPS Diluted | 22.34 | 13.86 | 11.08 | 8.07 | 7.14 | 5.16 | 4.56 | 2.18 | 0.90 | 1.05 | 2.66 | 1.23 |
| Weighted Avg Shares Out | 12.58M | 12.28M | 12.09M | 12.09M | 13.49M | 12.09M | 10.29M | 12.09M | 12.09M | 12.09M | 12.09M | 12.09M |
| Weighted Avg Shares Out (Dil) | 12.58M | 12.28M | 12.09M | 12.09M | 13.49M | 12.09M | 10.29M | 12.09M | 12.09M | 12.09M | 12.09M | 12.09M |
Source: https://incomestatements.info
Category: Stock Reports